# OnCo record paper-jean-pascal-machiels-lancet-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-jean-pascal-machiels-lancet-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-jean-pascal-machiels-lancet-2019" ;
  schema:name "Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study"@en ;
  schema:description "Paper by Jean-Pascal Machiels indexed on Europe PMC as PubMed record 30509740, in The Lancet (2019), one of the most cited records naming an author with this name at King Albert II Cancer Institute, Cliniques universitaires Saint-Luc."@en ;
  schema:url <https://onco.cc/key-papers/paper-jean-pascal-machiels-lancet-2019/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s0140-6736(18)31999-8>, <https://pubmed.ncbi.nlm.nih.gov/30509740/>, <https://europepmc.org/article/MED/30509740> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s0140-6736(18)31999-8> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Cohen EEW, Soulières D, Le Tourneau C, et al." ;
  onco:people <https://onco.cc/people/jean-pascal-machiels/> ;
  onco:journals <https://onco.cc/journals/lancet/> .